echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nankai University team develops new method to achieve targeted repair of vascular injury

    Nankai University team develops new method to achieve targeted repair of vascular injury

    • Last Update: 2021-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A research team led by Nankai University recently published a paper titled "Targeted Repair of Vascular Injury by Adipose-Derived Stem Cells Modified with P-Selectin Binding Peptide" in Advanced Science.


    Cardiovascular diseases, including coronary artery obstruction, have become the number one killer of human health


    Adipose-derived stem cells (ADSC) have become the main source of cells for tissue engineering and regenerative medicine because they are easy to isolate and self-renew


    DPP modification

    In this study, the researchers combined P-selectin-binding peptide (PBP) with polyethylene glycol-conjugated phospholipid derivative (DMPE-PEG) through the hydrophobicity between DMPE-PEG and the phospholipid bilayer.


    After identifying this DPP (DMPE-PEG-PBP) modification, they first evaluated the effect of the modification on the behavior of ADSCs


    Targeting of DPP-ADSC

    Next, the researchers evaluated the targeting ability of DPP-ADSC in vitro and in vivo


    In vivo experiments, guidewire-mediated injury of rat femoral arteries induced luminal expression of P-selectin


    DPP-ADSC repair arterial injury

    Afterwards, the researchers injected 5 × 10 −6 M DPP-ADSC into a rat femoral artery injury model by intravenous injection to evaluate its repair effect



    In theory, the ideal way to repair damaged arteries is to restore their original physiological structure


    When evaluating the repair mechanism of DPP-ADSC, they found that DPP-ADSC adheres to the surface of the damaged blood vessel, reduces the further adhesion of white blood cells and platelets, reduces the local inflammatory response, and effectively inhibits the intimal proliferation of the damaged blood vessel



    Finally, the researchers also evaluated the targeting ability of DPP-ADSC in a human femoral artery balloon injury model


    in conclusion


    In summary, the research team successfully used DPP to modify the cell membrane surface of ADSCs, and fully confirmed that ADSCs modified with 5 × 10 −6 M DPP have stronger targets for activated platelets, activated endothelial cells and damaged blood vessels.


    Original Search

    Yan H, Mi X, Midgley AC, Du X, Huang Z, Wei T, Liu R, Ma T, Zhi D, Zhu D, Wang T, Feng G, Zhao Y, Zhang W, He J, Zhu M, Kong D , Wang K.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.